Skip to main content
Helmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logo
Transfer, New Research Findings, VIRO,

Bioengineering Meets Hepatitis B: Researchers Design Promising Novel Therapeutic Candidates

Researchers have designed antibodies as novel therapeutic candidates for the treatment of chronic hepatitis B and hepatocellular carcinoma. Their study in human cell cultures and in living mice showed the elimination of antigen-positive cells and…

read more
Transfer, New Research Findings, Pioneer Campus,

Researchers Engineer an Organoid on Chip Platform to Recapitulate Pancreatic Organoids

A newly engineered organoid on chip platform mimics robustly key features of human pancreas development. This is a stepping stone towards reliable diagnostic solutions for early-stage pancreatic cancer. The study was carried out by an…

read more
Transfer, New Research Findings, TOXI,

First-in-class Cancer Immunotherapy Drug in Clinical Trial

A small molecule has entered a novel clinical trial for cancer immunotherapy. The molecule inhibits an enzyme called MALT1 that plays a critical role in suppressing immune reactions against tumor cells. Preclinical studies showed that blocking MALT1…

read more
Transfer, Awards & Grants, Molecular Targets and Therapeutics, STB,

Helmholtz Zentrum München Is the Recipient of the 2020 Erwin Schrödinger Prize

Researchers at Helmholtz Zentrum München and the University of Bochum received this year's Erwin Schrödinger Prize in recognition of their efforts to develop a cure for parasitic diseases such as Chagas disease with a new compound. The prize is…

read more
Transfer,

Research Cooperation between Helmholtz Zentrum München and Boehringer Ingelheim

The Helmholtz Zentrum München teams up with Boehringer Ingelheim in an endeavor to identify novel candidates for anti-obesity treatment.

read more
Transfer, New Research Findings, IDF,

Established Study Combines Early Detection of Type 1 Diabetes With Sars-Cov-2 Antibody Testing in Thousands of Children

Large-scale antibody testing against the new coronavirus SARS-CoV-2 could help to obtain reliable data on infection rates. Screening children for early stages of type 1 diabetes in Bavaria, "Fr1da-plus" will now integrate SARS-CoV-2 antibody testing…

read more

Press Contact

COMS Communications & Strategic Relations

Ingolstädter Landstr. 1